Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TPA | Ann: Removal of TPA at close of trading 02/10/2014 | 02/10/14 | 0 | 898 | |||
|
|||||||
TPA | Ann: Confirmation of Redemption of SPS Notes | 30/09/14 | 0 | 881 | |||
|
|||||||
TPA | Ann: Suspension of TPAPA at close of trading 10/09/2014 | 10/09/14 | 0 | 797 | |||
|
|||||||
TPA | Ann: REDEMPTION OF TRANSPACIFIC SPS | 21/08/14 | 0 | 1.4K | |||
|
|||||||
TPA | Ann: APP 4E / Full Year Statutory Accounts | 21/08/14 | 0 | 754 | |||
|
|||||||
TPI +TPA | Ann: TPI 2014 Results Release | 20/08/14 | 8 | 5.8K | |||
|
|||||||
TPA | Ann: Reinstatement to Official Quotation | 19/08/14 | 0 | 778 | |||
|
|||||||
TPI +TPA | Ann: TPI 2014 Results Investor Presentation | 19/08/14 | 0 | 844 | |||
|
See All Discussions